SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Fears of a Democratic sweep in the U.S. midterms dominate QQQ discussion, with traders attributing volatile Nasdaq selling to concerns about tech and AI regulation, including data-center scrutiny. Others call the reaction an overreaction because the outcome was widely expected and see the dip as a buying opportunity.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Midterm election returns and perceived Democratic gains dominate discussion, with traders debating whether a setback for Trump and Republicans could weigh on the Trump-linked stock. Bearish posts predict selling, while supporters argue the results are uncertain or reflect a typical midterm pattern.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs quarterly earnings beat and stronger-than-expected outlook, driven by surging AI data-center demand, are fueling a sharp post-results move and renewed optimism about growth. Traders remain divided over whether the rally can hold, with concerns about valuation, weaker cash flow and inventory, and reliance on data-center spending tempering the bullish reaction.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

A rebound in semiconductor shares, supported by strong AMD and SMCI earnings and renewed optimism about AI demand, is lifting SOXL after steep recent losses. Traders are divided between viewing the move as a relief rally and warning that election uncertainty, tech-sector selling, and the funds 3x leverage could keep volatility high.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros stronger-than-expected quarterly results and raised full-year outlook, attributed to robust AI-server demand, are driving attention. Many traders view the growth as bullish, while others question whether thin margins, cash-flow pressures and lingering doubts about management justify the muted share-price reaction.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a sharp neocloud and AI-infrastructure selloff, with traders worried that a Democratic midterm sweep could bring tighter limits on data-center development; concerns about debt financing and whether AI demand will justify heavy investment are adding pressure. The community is split between expecting an oversold rebound ahead of earnings and warning that funding risks and weak sector sentiment could drive further losses.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

AMDs strong results and outlook are fueling a semiconductor rebound, with traders treating them as evidence that AI-chip demand remains resilient ahead of Nvidias earnings. The optimism is tempered by election-related concerns about AI policy and by debate over whether Nvidias bounce can hold after recent selling.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles large stock-and-bond financing for its AI data-center buildout is driving debate: many traders worry about dilution, borrowing costs and whether AI spending will generate enough cash flow, while others see the completed raise as removing a funding overhang. The stocks rebound has prompted talk of a possible reversal or short squeeze, though skepticism about its financing and execution risks remains.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

A Q3 revenue miss and concerns about buildout costs and financing have fueled sharp swings in CIFR. Bulls point to its first HPC lease revenue and longer-term data-center contracts, while skeptics question execution and dilution and some traders attribute the rebound to an oversold bounce or short covering.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Election-related uncertainty is driving the discussion, with traders speculating that Democratic gains could bring greater scrutiny of Musk and SpaceX or threaten government contracts; others argue the companys business is resilient and the political fears are overblown. The debate is adding to volatility, alongside bullish and bearish views on the stocks direction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HUTCHMED (China) Reports H1 2026 Results: Full Earnings Call Transcript

HUTCHMED (China) (NASDAQ:HCM) released quarterly financial results and hosted an earnings call on Thursday. Read the complete transcript below.
This transcript is brought to you by Benzinga APIs. For real-time access toread more...

AZN Ends NSCLC Study for Bispecific Antibody Over Unlikely Success

AstraZeneca halts a phase III NSCLC study for volrustomig after data show that the regimen is unlikely to meet key survival goals, while other lung cancer trials shine.

Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating

Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating...

HUTCHMED (NASDAQ:HCM) Hits New 52-Week Low  - What's Next?

HUTCHMED (NASDAQ:HCM) Hits New 12-Month Low - What's Next...

HUTCHMED Highlights $1.4B Liquidity, 2026 Revenue Outlook, and SAFFRON Catalyst at DB Conference

HUTCHMED (NASDAQ:HCM) executives highlighted 2025 financial results, commercial momentum for its marketed oncology portfolio, and upcoming clinical and regulatory catalysts during a presentation at...

HUTCHMED (NASDAQ:HCM) Shares Gap Down - Here's Why

HUTCHMED (NASDAQ:HCM) Shares Gap Down - Here's Why...

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Given Average Rating of "Hold" by Analysts

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM - Get Free Report) has been given an average rating of "Hold" by the six ratings firms that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold...

Short Interest in HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Decreases By 13.7%

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM - Get Free Report) saw a large decrease in short interest during the month of March. As of March 13th, there was short interest totaling 278,317 shares, a decrease of 13.7% from the February 26th total of 322,619 shares. Currently, 0.2% of the...

HUTCHMED (NASDAQ:HCM) Shares Gap Up   - Time to Buy?

HUTCHMED (NASDAQ:HCM) Shares Gap Up - Time to Buy...

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM) Receives Consensus Recommendation of "Hold" from Brokerages

HUTCHMED (China) Limited Sponsored ADR (NASDAQ:HCM - Get Free Report) has been given a consensus rating of "Hold" by the six ratings firms that are presently covering the stock, Marketbeat Ratings...

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

HUTCHMED (China) Limited - ADR

Hutchmed Stock Hits Over One-Month High After China Accepts Kidney Cancer NDA Filed With Partner Innovent Biologics

Equity

Neutral Sentiment

Shares of Hutchmed (China) hit their highest levels in over a month after the company announced along with Innovent Biologics that their NDA for a kidney cancer treatment had been accepted by China's drug regulator.At the close on Wednesday, Hutchmed shares rose 4.1% to $15.3, with an additional 0.5% gain to $15.38 in after-hours trading.The China National Medical Products Administration (NMPA) accepted for review the NDA for fruquintinib combined with sintilimab as a treatment for patients with advanced renal cell carcinoma who did not respond to tyrosine kinase inhibitor therapy, according to a joint company statement.Results of the FRUSICA-2 trial showed the drug met its primary progression-free survival goal and also improved secondary measures such as objective response rate and duration of response.“Submitting this NDA...marks an important step in our efforts to address this unmet need,” said Michael Shi, head of R&amp;D and chief medical officer at Hutchmed.Hui Zhou, senior vice president at Innovent, said the filing represents the tenth indication for sintilimab, calling it a milestone in lifecycle management.The combination therapy received conditional approval from the NMPA in December 2024 for patients with advanced mismatch repair proficient endometrial cancer.Fruquintinib is approved in China under the brand Elunate and is marketed globally as Fruzaqla by Takeda.&nbsp;Sintilimab, co-developed by Innovent and Eli Lilly, is approved for multiple indications and included in China’s national reimbursement list.On Stocktwits, retail sentiment was ‘neutral’ amid ‘high’ message volume.The stock has risen 1.5% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Illustration depicting tumour infiltrating lymphocyte (TIL) therapy for cancer treatment. During TIL therapy, T-cells (blue) that recognise tumour cells (red) are obtained from a patient. | Image source: Getty Images

China's drug regulator accepted the companies’ NDA for a combination therapy targeting advanced renal cell carcinoma.

Current Price	$13.08
Prev Close	$13.27
Open	$13.25
Dividend Yield	0.00%
50-Day Moving Average	$13.68
Beta	0.86
Avg. Volume	46,113.74
PE Ratio	128.61

52-Week High	$16.33
52-Week Low	$9.77
Market Capitalization	$2.28B
EPS (Annual)	$2.62
Price to Book	1.81
Revenue Per Employee	$306,215.29

Feed

News

Sentiment

Earnings

Fundamentals

Info

HCM Fundamentals